O-[18F]fluoromethyl-L-tyrosine is a potential tracer for monitoring tumour response to chemotherapy using PET: An initial comparative in vivo study with deoxyglucose and thymidine

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 33, Issue 10, 2006, Pages 1134-1139

  Yamaura, Gengo ^a   Yoshioka, Takashi ^a   Fukuda, Hiroshi ^a   Yamaguchi, Keichiro ^a   Suzuki, Manami ^a   Furumoto, Shozo ^a   Iwata, Ren ^a   Ishioka, Chikashi ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

18F fluorodeoxyglucose; 3H thymidine; Cancer chemotherapy; O 18F fluoromethyl L tyrosine; PET

Indexed keywords

DEOXYGLUCOSE; FLUOROMETHYL TYROSINE OCTREOTIDE F 18; MITOMYCIN; THYMIDINE; TRACER; UNCLASSIFIED DRUG; ANTINEOPLASTIC ANTIBIOTIC; CARBON; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT; TRITIUM;

AMINO ACID TRANSPORT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CONTROLLED STUDY; IN VIVO STUDY; INFLAMMATORY CELL; LIVER CELL CARCINOMA; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RAT; TUMOR VOLUME; ANIMAL; COMPARATIVE STUDY; EVALUATION; FEASIBILITY STUDY; LIVER TUMOR; METHODOLOGY; PILOT STUDY; PROGNOSIS; SCINTISCANNING; TREATMENT OUTCOME; TUMOR CELL LINE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CARBON RADIOISOTOPES; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DEOXYGLUCOSE; FEASIBILITY STUDIES; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MITOMYCIN; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; RATS; THYMIDINE; TREATMENT OUTCOME; TRITIUM;

EID: 33749238212     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-006-0126-2     Document Type: Article

References (34)

1. Warburg O. On the origin of cancer cells. Science 1956;123:309-14
2. Gambhir SS, Czernin J, Schwimmer J, Silverman DH, Coleman RE, Phelps ME. A tabulated summary of the FDG PET literature. J Nucl Med 2001;42:1S-93S
3. 3H]thymidine, and gallium-67. J Nucl Med 1991;32:2118-23
4. Yoshioka T, Takahashi H, Oikawa H, Maeda S, Ido T, Akaizawa T, et al. Influence of chemotherapy on FDG uptake by human cancer xenografts in nude mice. J Nucl Med 1997;38:714-7
5. 18F-FDG PET evaluation of the response to therapy for lymphoma and for breast, lung, and colorectal carcinoma. J Nucl Med 2003;44:224-39
6. Kostakoglu L, Goldsmith SJ. PET in the assessment of therapy response in patients with carcinoma of the head and neck and of the esophagus. J Nucl Med 2004;45:56-68
7. Weber WA. Use of PET for monitoring cancer therapy and for predicting outcome. J Nucl Med 2005;46:983-95
8. Kubota R, Kubota K, Yamada S, Tada M, Ido T, Tamahashi N. Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18- fluorodeoxyglucose uptake. J Nucl Med 1994;35:104-12
9. Weber G. Biochemical strategy of cancer cells and the design of chemotherapy: G. H. A. Clowes Memorial Lecture. Cancer Res 1983;43:3466-92
10. Jager PL, Vaalburg W, Pruim J, de Vries EG, Langen KJ, Piers DA. Radiolabeled amino acids: basic aspects and clinical applications in oncology. J Nucl Med 2001;42:432-45
11. 11C]methionine. J Nucl Med 1987;28:1037-40
12. Kubota K, Matsuzawa T, Ito M, Ito K, Fujiwara T, Abe Y, et al. Lung tumor imaging by positron emission tomography using C-11 L-methionine. J Nucl Med 1985;26:37-42
13. 11C]methionine. Int J Radiat Oncol Biol Phys 1994;30:1195-9
14. Lindholm P, Leskinen S, Nagren K, Lehikoinen P, Ruotsalainen U, Teras M, et al. Carbon-11-methionine PET imaging of malignant melanoma. J Nucl Med 1995;36:1806-10
15. Jansson T, Westlin JE, Ahlstrom H, Lilja A, Langstrom B, Bergh J. Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: a method for early therapy evaluation? J Clin Oncol 1995;13:1470-7
16. 11C-methionine positron emission tomography and proliferating cell nuclear antigen staining. Neurosurg Rev 1999;22:210-4
17. Laverman P, Boerman OC, Corstens FH, Oyen WJ. Fluorinated amino acids for tumour imaging with positron emission tomography. Eur J Nucl Med Mol Imaging 2002;29:681-90
18. 18F]fluorotyrosine, a new PET tracer of protein synthesis. J Nucl Med 1989;30:1367-72
19. Ishiwata K, Enomoto K, Sasaki T, Elsinga PH, Senda M, Okazumi S, et al. A feasibility study on L-[1-carbon-11]tyrosine and L-[methyl-carbon-11]methionine to assess liver protein synthesis by PET. J Nucl Med 1996;37:279-85
20. 18F]fluoroethyl)- L-tyrosine for tumor imaging. J Nucl Med 1999;40:205-12
21. Inoue T, Tomiyoshi K, Higuichi T, Ahmed K, Sarwar M, Aoyagi K, et al. Biodistribution studies on L-3-[fluorine-18] fluoro-alpha-methyl tyrosine: a potential tumor-detecting agent. J Nucl Med 1998;39:663-67
22. 11C]methionine. Jpn J Cancer Res 1989;80:778-82
23. 18F]fluoromethyl-L- tyrosine as potential PET tracers for imaging amino acid transport. J Label Compd Radiopharm 2003;46:555-66
24. 18F] fluoromethyl-L-tyrosine as tumor imaging tracers by PET. Nucl Med Biol 2004;31:191-98
25. Kubota K, Matsuzawa T, Takahashi T, Fujiwara T, Kinomura S, Ido T, et al. Rapid and sensitive response of carbon-11-L-methionine tumor uptake to irradiation. J Nucl Med 1989;30:2012-016
26. 18F]fluoroethyl)-L-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes. Eur J Nucl Med Mol Imaging 2002;29:1039-46
27. 18F]fluoromethyl-L-tyrosine for differentiation between tumor and inflammatory tissues. Ann Nucl Med 2005;19:589-95
28. Kubota R, Kubota K, Yamada S, Tada M, Ido T, Tamahashi N. Active and passive mechanisms of [fluorine-18] fluorodeoxyglucose uptake by proliferating and prenecrotic cancer cells in vivo: a microautoradiographic study. J Nucl Med 1994;35:1067-75
29. Haberkorn U, Bellemann ME, Brix G, Kamencic H, Morr I, Traut U, et al. Apoptosis and changes in glucose transport early after treatment of Morris hepatoma with gemcitabine. Eur J Nucl Med 2001;28:418-25
30. 18F]fluorocholine. Appl Radiat Isot 2002;57:347-52
31. Shields AF, Grierson JR, Dohmen BM, Machulla HJ, Stayanoff JC, Lawhorn-Crews JM, et al. Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nat Med 1998;4:1334-336
32. 18F-FDG. J Nucl Med 2003;44:1426-31
33. 18F-fluorothymidine PET. J Nucl Med 2005;46:114-20
34. 18F-fluoroethyl)-L-tyrosine in peripheral tumors: first clinical results. J Nucl Med 2005;46:411-6